Status:
COMPLETED
Characterizing and Addressing Financial Toxicity in AYAs With Cancer
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Patient Advocate Foundation
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Cancer in Adolescence
Eligibility:
All Genders
15-39 years
Phase:
NA
Brief Summary
The overall aims of this study are to address two important gaps in care for AYA cancer patients: 1) a financial toxicity measurement tool to assess AYA-specific needs, and 2) an intervention for miti...
Detailed Description
Financial toxicity is the harmful personal financial burden faced by patients due to healthcare needs. A prevalent adverse outcome of cancer therapy, financial toxicity is associated with poorer healt...
Eligibility Criteria
Inclusion
- AYA patient participants:
- Age 15 - 39 years old
- English or Spanish-speaking
- Diagnosed with cancer that required treatment within past 18 months
- Not currently on hospice care
- Caregiver/financial partner participants:
- Parent or financially-responsible adult of non-adult AYA (\<18 years) OR
- Identified by the AYA as caregiver, parent, or partner who is financially-responsible or a financial partner for AYA
Exclusion
- Unable to complete financial survey questions or contraindicated (as outlined in Protection of Human Subjects)
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06072833
Start Date
November 15 2023
End Date
February 28 2025
Last Update
July 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032